Mariner
GH icon

Mariner’s Guardant Health GH Stock Holding History

Mariner’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$788K Buy
8,541
+2,930
+52% +$294K ﹤0.01% 2141
2025
Q4 		$572K Buy
5,611
+1,690
+43% +$151K ﹤0.01% 2355
2025
Q3 		$245K Sell
3,921
-2,779
-41% -$151K ﹤0.01% 2992
2025
Q2 		$349K Buy
6,700
+180
+3% +$8.04K ﹤0.01% 2610
2025
Q1 		$278K Buy
+6,520
New +$281K ﹤0.01% 2696
2024
Q1 		– Sell
-13,384
Closed -$362K – 3176
2023
Q4 		$362K Buy
+13,384
New +$351K ﹤0.01% 2185
2023
Q3 		– Sell
-16,987
Closed -$608K – 2954
2023
Q2 		$608K Buy
16,987
+6,000
+55% +$172K ﹤0.01% 1609
2023
Q1 		$258K Buy
+10,987
New +$314K ﹤0.01% 2191
2022
Q4 		– Sell
-5,321
Closed -$286K – 2775
2022
Q3 		$286K Buy
+5,321
New +$273K ﹤0.01% 1805

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mariner's GH Position: Q1 2026 in Review

Mariner increased its Guardant Health (GH) stake by 52% in Q1 2026, buying an estimated $294K and bringing the position to 8,541 shares worth $788K. The position accounts for ﹤0.01% of the portfolio, ranked #2141.

Mariner first reported a position in GH in Q3 2022 and has held it in 9 quarters since. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Mariner held 8,541 shares of Guardant Health worth $788K as of Q1 2026.
  • Mariner bought 2,930 Guardant Health shares in Q1 2026, an estimated $294K.
  • Guardant Health made up ﹤0.01% of Mariner's portfolio in Q1 2026, its #2141 holding.
  • Mariner first reported a position in Guardant Health in Q3 2022 and has held it in 9 quarters since.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Mariner's 13F filing for Q1 2026, filed 13 May 2026.